UCL-TRO-1938

N/A

Report date: 2023/05/30 14:13:28
NME

Base Information

Drug NameUCL-TRO-1938
Drug Alias NameUCL-TRO-1938
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha activators
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsMyocardial Reperfusion InjuryTrauma, Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity College London
China Registration ClassN/A

Develop Information

Active CompaniesUniversity College London
Inactive CompaniesN/A
Active IndicationsMyocardial Reperfusion InjuryTrauma, Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A